Cancer stem cell theory is the theory that tumors arise from cells termed cancer stem cells that have properties of normal stem cells, particularly the abilities to self-renew and differentiate into multiple cell types, and that these cells persist in tumors as a distinct population that likely causes disease relapse and metastasis. Tumor (American English) or tumour (British English) originally means swelling, and is sometimes still used with that meaning. ... A cell is a single unit or compartment, enclosed by a border or wall. ... A relapse (etymologically, who falls again) occurs when a person is affected again by a condition that affected them in the past. ... Metastasis (Greek: change of the state) is the spread of cancer from its primary site to other places in the body. ...

Stem cell specific and conventional cancer therapies

The main question posed by proponents of the theory is "Are we targeting the right kind of cell?" Most existing cancer treatments were developed on animal models, where therapies able to promote tumor shrinkage were deemed effective. However, animals could not provide a complete model of human disease. In particular, in mice, whose life spans do not exceed two years, tumor relapse is exceptionally difficult to study and was largely neglected by most researchers. The theory suggests that conventional chemotherapies kill differentiated or differentiating cells, which form the bulk of the tumor but are unable to generate a new one. A population of cancer stem cells, which gave rise to it, remains untouched and may cause a relapse of the disease. Image File history File links Cancer_stem_cells_text_resized. ... Image File history File links Cancer_stem_cells_text_resized. ... Animal model refers to a non-human animal with a disease that is similar to a human condition. ... Chemotherapy is the use of chemical substances to treat disease. ...

Development of specific therapies targeted at cancer stem cells holds hope for improvement of survival and quality of life of cancer patients, especially for sufferers of metastatic disease, where little progress has been made in recent years. Metastasis (Greek: change of the state) is the spread of cancer from its primary site to other places in the body. ...

Evidence for cancer stem cells

Opponents of the paradigm do not deny the existence of cancer stem cells as such. Cells with some degree of "stemness", especially with unlimited self-renewal potential, must exist to sustain the growth of a tumor. However, it is debated whether such cells represent a minority. If most cells of the tumor are endowed with stem cell properties there is no incentive to focusing on a specific subpopulation.

In cancer research experiments, tumor cells are sometimes injected into an experimental animal to establish a tumor. Disease progression is then followed in time and novel drugs can be tested for their ability to inhibit it. However, efficient tumor formation requires thousands or tens of thousands of cells to be introduced. Classically, this has been explained by poor methodology (i.e. the tumor cells lose their viability during transfer) or the critical importance of the microenvironment, the particular biochemical surroundings of the injected cells. Supporters of the cancer stem cell paradigm argue that only a small fraction of the injected cells, the cancer stem cells, have the potential to generate a tumor. In human acute myeloid leukemia the frequency of these cells is less than 1 in 10,000.^[1] Cancer research is research into cancer in order to identify causes and develop strategies for prevention, diagnosis, treatments and cure. ... Enos the space chimp before insertion into the Mercury-Atlas 5 capsule in 1961. ... Viability can mean: In an environmental conservation context, viability indicates the ability of a conservation target to persist for many generations or over long time periods. ... Acute myeloid leukemia (AML), which is also known as acute myelogenous leukemia, is a cancer of the myeloid line of white blood cells, characterized by the rapid proliferation of abnormal cells which accumulate in the bone marrow and interfere with the production of normal blood cells. ...

Further evidence comes from histology, the study of tissue structure of tumors. Many tumors are very heterogeneous and contain multiple cell types native to the host organ. Heterogeneity is commonly retained by tumor metastases. This implies that the cell that produced them had the capacity to generate multiple cell types. In other words, it possessed multidifferentiative potential, a classical hallmark of stem cells.^{[citation needed]} A thin section of lung tissue stained with hematoxylin and eosin. ... Look up Heterogeneous in Wiktionary, the free dictionary. ... A cell type is a distinct morphological or functional form of cell. ...

The idea of cancer cells arising from a common origin has been thoroughly explained and published as the Unitarian or Trophoblastic thesis of cancer in the July 1950 issue of the Medical Record. It states that cancer -- differentiated trophoblast proliferation -- is part of the healing process, and the disease only manifests if its control (immune response and nutrition) are impeded. A request has been made on Wikipedia for this article to be deleted in accordance with the deletion policy. ... It has been suggested that Diet (nutrition) be merged into this article or section. ...

Mechanistic and mathematical models

Once the pathways to cancer are hypothesized, it is possible to develop predictive mathematical biology models,^[2] e.g., based on the cell compartment method. For instance, the growths of the abnormal cells from their normal counterparts can be denoted with specific mutation probabilities. Such a model has been be employed to predict that repeated insult to mature cells increases the formation of abnormal progeny, and hence the risk of cancer.^[3] Considerable work needs to be done, however, before the clinical efficacy of such models is established. This article or section contains inappropriate citations. ... A population comprises a large number of individuals, all of whom are different in various fields. ...

Cancer stem cell pathways

A normal stem cell may be transformed into a cancer stem cell through disregulation of the proliferation and differentiation pathways controlling it. Scientists working on cancer stem cells hope to design new drugs targeting these cellular mechanisms. The first findings in this area were made using haematopoietic stem cells (HSCs) and their transformed counterparts in leukemia, the disease whose stem cell origin is most strongly established. However, these pathways appear to be shared by stem cells of all organs. Stem cell division and differentiation. ... Cell signaling is part of a complex system of communication that governs basic cellular activities and coordinates cell actions. ... Drug design is the approach of finding drugs by design, based on their biological targets. ... Mouse embryonic stem cells. ... Leukemia (or leukaemia; see spelling differences) is a cancer of the blood or bone marrow characterized by an abnormal proliferation of blood cells, usually white blood cells (leukocytes). ...

Bmi-1

The Polycomb group transcriptional repressor Bmi-1 was discovered as a common oncogene activated in lymphoma^[4] and later shown to specifically regulate HSCs^[5]. The role of Bmi-1 has also been illustrated in neural stem cells.^[6] The pathway appears to be active in cancer stem cells of pediatric brain tumors.^[7] Transcription is the process through which a DNA sequence is enzymatically copied by an RNA polymerase to produce a complementary RNA. Or, in other words, the transfer of genetic information from DNA into RNA. In the case of protein-encoding DNA, transcription is the beginning of the process that ultimately... A repressor a protein that can regulate a gene by turning it on and off. ... An oncogene is a modified gene that increases the malignancy of a tumor cell. ... Lymphoma is a general term for cancers that develop in the lymphatic system. ... Pediatrics (also spelled paediatrics or pædiatrics) is the branch of medicine that deals with the medical care of infants and children. ... A brain tumor is any intracranial tumor created by abnormal and uncontrolled cell division, normally either found in the brain itself (neurons, glial cells (astrocytes, oligodendrocytes, ependymal cells), lymphatic tissue, blood vessels), in the cranial nerves (myelin-producing Schwann cells), in the brain envelopes (meninges), skull, pituitary and pineal gland...

Notch

The Notch pathway has been known to developmental biologists for decades. Its role in control of stem cell proliferation has now been demonstrated for several cell types including haematopoietic, neural and mammary^[8] stem cells. Components of the Notch pathway have been proposed to act as oncogenes in mammary^[9] and other tumors. The Notch pathway is a gene regulatory pathway involved in multiple differentiation processes. ...

Sonic hedgehog and Wnt

These developmental pathways are also strongly implicated as stem cell regulators.^[10] Both Sonic hedgehog(SHH) and Wnt pathways are commonly hyperactivated in tumors and are required to sustain tumor growth. However, the Gli transcription factors that are regulated by SHH take their name from gliomas, where they are commonly expressed at high levels. A degree of crosstalk exists between the two pathways and their activation commonly goes hand-in-hand.^[11] This is a trend rather than a rule. For instance, in colon cancer hedgehog signalling appears to antagonise Wnt.^[12] Sonic hedgehog homolog (SHH) is one of five proteins in the vertebrate hedgehog (HH) family thus far described, the others being desert hedgehog (DHH), Indian hedgehog (IHH), echidna hedgehog (EHH) and tiggywinkle hedgehog (TwHH). ... The wnt signaling pathway is a network of proteins that has been implicated in embryogenesis and cancer. ... A glioma is a type of primary central nervous system (CNS) tumor that arises from glial cells. ... In biology, the term crosstalk refers to the phenomenon that signal components in signal transduction can be shared between different signal pathways and responses to a signal inducing condition (e. ...

External links

• "Cancer Stem Cell Scientific Literature Review", UMDNJ Stem Cell Research and Regenerative Medicine, June 17, 2006
• "Stem cells may cause some forms of bone cancer", News-Medical.Net, December 7, 2005
• "The Bad Seed: Rare stem cells appear to drive cancers", Science News Online, March 20, 2004
• "The Real Problem in Breast Tumors: Cancer Stem Cells", Genome News Network, March 7, 2003
• [1] Stem Cell and Cord Blood information database

June 17 is the 168th day of the year in the Gregorian calendar (169th in leap years), with 197 days remaining. ... 2006 (MMVI) is a common year starting on Sunday of the Gregorian calendar. ... December 7 is the 341st day (342nd in leap years) of the year in the Gregorian calendar. ... 2005 (MMV) was a common year starting on Saturday of the Gregorian calendar. ... March 20 is the 79th day of the year in the Gregorian Calendar (80th in Leap years). ... 2004 (MMIV) was a leap year starting on Thursday of the Gregorian calendar. ... March 7 is the 66th day of the year in the Gregorian Calendar (67th in leap years). ... 2003 (MMIII) was a common year starting on Wednesday of the Gregorian calendar. ...

References

Dr. John E. Dick PhD FRSC (born 1957) is an award-winning Canadian scientist, credited with first identifying Cancer stem cells in certain types of leukemia. ... The Entrez logo The Entrez Global Query Cross-Database Search System allows access to databases at the National Center for Biotechnology Information (NCBI) website. ... The Entrez logo The Entrez Global Query Cross-Database Search System allows access to databases at the National Center for Biotechnology Information (NCBI) website. ... The Entrez logo The Entrez Global Query Cross-Database Search System allows access to databases at the National Center for Biotechnology Information (NCBI) website. ... The Entrez logo The Entrez Global Query Cross-Database Search System allows access to databases at the National Center for Biotechnology Information (NCBI) website. ... The Entrez logo The Entrez Global Query Cross-Database Search System allows access to databases at the National Center for Biotechnology Information (NCBI) website. ... PubMed Central grew from the online Entrez PubMed biomedical literature search system. ... PubMed Central grew from the online Entrez PubMed biomedical literature search system. ... The Entrez logo The Entrez Global Query Cross-Database Search System allows access to databases at the National Center for Biotechnology Information (NCBI) website. ... The Entrez logo The Entrez Global Query Cross-Database Search System allows access to databases at the National Center for Biotechnology Information (NCBI) website. ... The Entrez logo The Entrez Global Query Cross-Database Search System allows access to databases at the National Center for Biotechnology Information (NCBI) website. ... The Entrez logo The Entrez Global Query Cross-Database Search System allows access to databases at the National Center for Biotechnology Information (NCBI) website. ...